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Abstract
AIM
To validate the feasibility of high resolution computed 
tomography (HRCT) of the lung prior to computed 
tomography angiography (CTA) in assessing incidental 
thoracic findings during endovascular aortic aneurysm 
repair (EVAR) planning or follow-up. 
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METHODS
We conducted a retrospective study among 181 pa-
tients (143 men, mean age 71 years, range 50-94) re-
ferred to our centre for CTA EVAR planning or follow-
up. HRCT and CTA were performed before or after 1 
or 12 mo respectively to EVAR in all patients. All HRCT 
examinations were reviewed by two radiologists with 15 
and 8 years’ experience in thoracic imaging. The results 
were compared with histology, bronchoscopy or follow-up 
HRCT in 12, 8 and 82 nodules respectively. 
RESULTS
There were a total of 102 suspected nodules in 92 HRCT 
examinations, with a mean of 1.79 nodules per patient and 
an average diameter of 9.2 mm (range 4-56 mm). Eighty-
nine out of 181 HRCTs resulted negative for the presence 
of suspected nodules with a mean smoking history of 
10 pack-years (p-y, range 5-18 p-y). Eighty-two out of 
102 (76.4%) of the nodules met criteria for computed 
tomography follow-up, to exclude the malignant evo-
lution. Of the remaining 20 nodules, 10 out of 20 (50%) 
nodules, suspected for malignancy, underwent biopsy and 
then surgical intervention that confirmed the neoplastic 
nature: 4 (20%) adenocarcinomas, 4 (20%) squamous 
cell carcinomas, 1 (5%) small cell lung cancer and 1 (5%) 
breast cancer metastasis); 8 out of 20 (40%) underwent 
bronchoscopy (8 pneumonia) and 2 out of 20 (10%) 
underwent biopsy with the diagnosis of sarcoidosis.
CONCLUSION
HRCT in EVAR planning and follow-up allows to correctly 
identify patients requiring additional treatments, especially 
in case of lung cancer.
Key words: Computed tomography angiography; Aorta; 
Endovascular aortic aneurysm repair; Cigarette smoking; 
Lung cancer
© The Author(s) 2017. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Nowadays the use of high resolution computed 
tomography in endovascular aortic aneurysm repair (EVAR) 
patients planning and follow up is not recommended yet. 
Our study demonstrates the possibility to early diagnose 
lung cancer during EVAR follow-up or planning in smoker 
patients, overcoming the concept of dose radiation induced 
neoplasms, especially in over 65 years old patients. 
Mazzei MA, Guerrini S, Gentili F, Galzerano G, Setacci F, 
Benevento D, Mazzei FG, Volterrani L, Setacci C. Incidental 
extravascular findings in computed tomographic angiography 
for planning or monitoring endovascular aortic aneurysm repair: 
Smoker patients, increased lung cancer prevalence? World J 
Radiol 2017; 9(7): 304-311  Available from: URL: http://www.
wjgnet.com/1949­8470/full/v9/i7/304.htm  DOI: http://dx.doi.
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INTRODUCTION
Vascular diseases cover an extended selection of 
pathologies comprising cardiovascular, thoracoa­
bdominal, peripheral vascular and cerebrovascular 
disease[1]. Smoking is considered one of the main 
risk factors for the development of atherosclerosis 
and, in particular, oxidative stress and inflammation 
that constitute the physiological connection between 
smoking and vascular diseases. Polycyclic aromatic 
hydrocarbons (PAH) represent the main carcinogenic 
compound found in cigarettes, produced during the 
incomplete combustion of organic matter. Many ar­
ticles demonstrate the double activity of PAH, both 
carcinogenic (lung and other tissues) and inflammatory, 
provoking endothelial dysfunction and several studies 
demonstrate that oxidants directly impair endothelial 
function, increasing nitric oxide scavenging by oxygen 
free radicals[2­6]. In the literature it is well known that 
cardiovascular diseases are often diagnosed on the basis 
of imaging findings, such as suspected atherosclerotic 
plaques of the chest in computed tomography (CT), also 
incidentally[7­9]. A similar approach should be used to 
identify extravascular findings, when the CT examination 
is required to explore vascular diseases. In particular, 
since cigarette smoking is the main risk factor for both 
vascular and neoplastic lung diseases, radiologists 
should examine the chest in evaluation of vascular 
patients with many risk factors suggesting possible 
synchronous pathologies. It has been reported that CTs 
requested for the exclusion of pulmonary embolism give 
a high yield of chest abnormalities, such as mediastinal 
adenopathy, paratracheal adenopathy, atelectasis, 
emphysema and pulmonary nodules or masses[10,11]. 
Although not the target of the investigation, lung 
abnormalities, especially lung cancer, could become the 
main finding with prognostic relevance in terms of life-
long survivor risk in vascular patients. Furthermore, 
even if many articles over the last decade have 
reported the problem of unsuspected thoracic findings 
in CTs performed for suspected pulmonary embolism 
or thoracic aortic pathology, the possibility of finding 
chest pathology, and in particular lung cancer in smoker 
patients suffering from vascular disease, has been 
underestimated[12,13]. Moreover, several articles have 
reported a high cumulative radiation dose in patients 
treated with endovascular aneurysm repair (EVAR), 
both during the interventional procedure and CT follow­
up, suggesting a possible role of radiation exposure 
in developing cancer in these patients[14­16]. On the 
contrary, there have been no articles to date about 
the discovery of lung cancer during EVAR planning or 
surveillance in smokers suggesting that smoking rather 
than the exposure of patients to radiation is the main 
risk factor for lung cancer. Considering the previous 
statements, the purpose of this study is to assess the 
prevalence of lung cancer in patients with a smoking 
306 July 28, 2017|Volume 9|Issue 7|WJR|www.wjgnet.com
attitude, who underwent computed tomography angio­
graphy (CTA) for planning or monitoring EVAR in our 
department. 
MATERIALS AND METHODS
Patient characteristics
Institutional review board approval was obtained for 
this retrospective study, as well as informed consent 
from all subjects. We reviewed the report results of 250 
CTs of patients referred to our department for EVAR 
planning or follow­up between June 2014 and May 
2016, searching for lung abnormalities in the patients 
who underwent high resolution computed tomography 
(HRCT) of the lung before contrast agent administration. 
Patients were identified throughout a digital radiological 
database (Picture Archive and Communication System, 
PACS) which registers all radiological studies performed 
by the Department of Radiology. The mean age of 
patients at the time of CT was 71 years, in a range from 
50 to 94, and 38 (21%) were female. Sixty­nine (26.6%) 
patients were excluded for the following reasons: 30 
(43.5%) because of the absence of synchronous chest 
HRCT, 21 (30.4%) because of lack of proven histological 
findings of lung cancer or HRCT follow-up examinations, 
and 18 (26.1%) because of non­smoking attitude. The 
CTA and HRCT were performed simultaneously in all 
selected cases to avoid interpretation bias. Seventy­four 
(40.8%) CTs were performed for EVAR planning and 
107 for EVAR surveillance (67 at 1 mo and 40 at 12 mo 
after EVAR). All the selected patients had a documented 
history of smoking [number of pack­years (p­y)][17­19]. 
Imaging technique
All the CTs were performed with a 64­detector row CT 
scanner (Discovery HD 750, General Electric Healthcare, 
and Milwaukee, United States). HRCTs were acquired 
at end of inspiration using volumetric technique in 
the caudocranial direction from the basis to the apex 
of the lung; patients were in supine position. The 
following technical parameters were used: Effective 
slice thickness 3.75 mm, collimation 40 mm, beam 
pitch 0.969, reconstruction interval 1 mm, tube voltage 
140 kVp and reference mAs 250/400. Automatic tube 
current modulation was used to minimise radiation 
exposure. Chest CTs were acquired using a standard 
algorithm, then data were reconstructed by using a high 
spatial­frequency algorithm (bone plus), with 1.25 mm 
slice thickness. Abdominal CT angiography (CTA) was 
performed with a spiral technique in the caudocranial 
direction (from the pelvic brim to the lung bases) with 
the patients supine. Patients were instructed to hold 
their breath during helical imaging to avoid motion 
artefacts. After a scout­view scan, intravenous injection 
of 1.5 mL/kg non­ionic contrast material (Iomeprol 
400 mg iodine/mL; Iomeron 400, Bracco Diagnostics, 
Milan, Italy) followed by 40 mL saline solution was 
administered with an 18­gauge needle in the antecubital 
vein, using a dual-barrel injector (4 mL/s flow rate, CT 
Motion, Ulrich Medical, Ulm, Germany). Arterial phase 
images were obtained 4 seconds after bolus detection in 
the suprarenal aorta. The following technical parameters 
were used: Effective slice thickness 1.25 mm, colli­
mation 40 mm, beam pitch 0.969, reconstruction 
interval 0.8 mm, tube voltage 140 kVp and reference 
mAs 250/700. A standard reconstruction algorithm was 
used. In 24 out of 181 patients (13.2%), the contrast 
CT was extended to the thorax using the same technical 
parameters. Automatic tube current modulation was 
also used to minimise radiation exposure in the post­
contrast examination[16].
Image analysis
All images were analysed independently and blindly by 
two readers with 15 and 8 years’ experience in chest­
imaging respectively. HRCT scans were analysed on 
a reconstruction and image interpretation console 
(Advantage Workstation 4.4, GE Healthcare, Milwaukee, 
Wis, United States), adjusting the image level, window 
and enlargement values each time, and routinely using 
a 2D multiplanar reconstruction technique (coronal, 
sagittal and oblique planes). Pulmonary HRCT findings 
included: Pleural effusion, atelectasis/pneumonia, 
pericardial effusion, cardiomegaly, coronary artery 
calcifications, bone findings, hiatal hernia, emphysema, 
mediastinal or hilar adenopathy, pulmonary micronodule 
(< 4 mm), pulmonary nodule (> 4 mm and < 30 
mm) and pulmonary mass (> 30 mm). The readers 
recorded any incidental finding, with particular attention 
to pulmonary nodules or masses and differences were 
resolved by consensus. All nodules were characterised 
by number, size (measured in their greatest diameter) 
and CT characteristic appearance (solid, ground­glass 
or partially solid, edge characteristics, speculated or 
smooth, presence or absence of pleural­tag, bronchus 
sign, calcifications, intralesional fat or intralesional 
air) and reviewed with the smoking history of the 
patient. According to Fleischner Society guidelines, all 
suspected nodules were addressed to CT biopsy or 
surgical intervention, whereas nodules with a CT low 
risk appearance for lung cancer were addressed to CT 
follow­up[20] (Table 1­4). All previous medical reports, 
clinical notes, discharges summaries and medical 
histories of patients were examined to potentially define 
every mass or nodule as a new incidental finding. 
Statistical analysis
The lung findings detected by the readers were co­
llected, and the results expressed as mean ± SD. A 
descriptive statistical analysis was performed; the 
quantitative variables were expressed as means and 
range whereas the qualitative values as percentages. 
The statistical review of the study was performed by 
a biomedical statistician. The analysis was performed 
using Stata version 8.0 (Stata Corp, College Station, 
Texas).
Mazzei MA et al . Incidental lung cancer in EVAR patients
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RESULTS
A total of 181 HRCTs were reviewed. The incidental 
lung findings reported on chest CT are shown in Table 
5. There were a total of 102 (56%) nodules in 92 out of 
181 (50.8%) HRCTs, with a mean of 1.79 nodules per 
patient and an average diameter of 9.2 mm, ranging 
from 4 to 56 mm. All the CT nodules characteristics 
are reported in Table 6. After radiologists’ review, 82 
(76.4%) of the nodules met criteria for CT follow­up 
and were submitted to a second HRCT examination 
(performed between 6­12 mo), to exclude the possibility 
of malignant evolution. Of the remaining 20 nodules, 
10 out of the 20 (50%) suspected for malignancy 
underwent biopsy and then surgical intervention which 
confirmed the following neoplastic nature: 4 (20%) 
adenocarcinomas (Figure 1), 4 (20%) squamous cell 
carcinomas, 1 (5%) small cell lung cancer and 1 (5%) 
breast cancer metastasis (Figure 2); 8 out of 20 (40%) 
underwent bronchoscopy (8 pneumonia) and 2 out 
of 20 (10%) underwent biopsy with the diagnosis of 
sarcoidosis. All the patients diagnosed with lung cancer 
(1 female and 8 males) had a smoking history with 
a mean quantity of 60 p­y (range 45­83 p­y). The 
remaining patients with non­neoplastic nodules had a 
smoking history with a mean quantity of 35 p­y (range 
20­46 p­y) per patient. Eighty­nine out of 181 HRCTs 
resulted negative for the presence of suspected nodules 
with a mean smoking history of 10 p­y (range 5­18 p­y).
DISCUSSION 
EVAR currently represents a safe and effective treat­
ment for abdominal aortic aneurysms exclusion with an 
increase in the choice of this treatment over traditional 
open repair, especially in elderly patients[21,22]. In 
particular, EVAR is also becoming the method of choice 
for aneurysmal sac exclusion in vascular patients 
Table 1  Recommendations for follow-up and management of single solid nodule[20]
Nodule size (mm) Low risk patient1 (mm) High risk patient2 (mm)
< 6 No routine FU Optional CT at 12 mo
6-8 CT at 6-12 mo, then consider CT at 18-24 mo CT at 6-12 mo, then CT at 18-24 mo
> 8 Consider CT, PET/CT, or tissue sampling at 3 mo Consider CT, PET/CT, or tissue sampling at 3 mo
1Minimal or absent history of smoking and of other known risk factors; 2A smoking history ≥ 30 p-y and quitting smoking within the past 15 years and/or 
the presence of other known risk factors. CT: Computed tomography; FU: Follow-up; PET: Positron emission tomography.
Mazzei MA et al . Incidental lung cancer in EVAR patients
Table 2  Recommendations for follow-up and management of multiple solid nodules[20]
Nodule size (mm) Low risk patient1 (mm) High risk patient2 (mm)
< 6 No routine FU Optional CT at 12 mo
6-8 CT at 3-6 mo, then consider CT at 18-24 mo CT at 3-6 mo, then at 18-24 mo
> 8 CT at 3-6 mo, then consider CT at 18-24 mo CT at 3-6 mo, then at 18-24 mo
1Minimal or absent history of smoking and of other known risk factors; 2A smoking history ≥ 30 p-y and quitting smoking within the past 15 years and/or 
the presence of other known risk factors. CT: Computed tomography; FU: Follow-up.
Table 3  Recommendations for follow-up and management of single subsolid nodule[20]
Nodule size (mm) Ground-glass Part solid
< 6 No routine FU No routine FU
≥ 6 CT at 6-12 mo to confirm persistence, then CT every 2 yr 
until 5 yr
CT at 3-6 mo to confirm persistence. If unchanged and solid 
component remains <6 mm, annual CT should be performed for 5 yr
CT: Computed tomography; FU: Follow-up.
Nodule size (mm)
< 6 CT at 3-6 mo. If stable, consider CT at 2 and 4 yr
≥ 6 CT at 3-6 mo. Subsequent management based on the most suspicious nodule(s)
Table 4  Recommendations for follow-up and management of multiple subsolid nodules[20]
CT: Computed tomography.
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Figure 1  Lepidic predominant adenocarcinoma diagnosed during endovascular aortic aneurysm repair follow-up. A-C: A 80-year-old male with a LPA of 
the right upper lobe diagnosed during endovascular aortic aneurysm repair follow-up for a type II endoleak treated with glue and coils (A). HRCT images (B and 
C) demonstrate the lepidic growth of the tumor and aerogenous metastases in the same lobe. LPA: Lepidic predominant adenocarcinoma; HRCT: High resolution 
computed tomography.
Figure 2  Breast cancer lung metastasis diagnosed during endovascular aortic aneurysm repair planning. A-C: A-63-year-old woman, with a history of breast 
cancer (10 year before,  pT1cN0M0), addressed to our institution for vascular planning due to an abdominal aortic aneurism (A). HRCT image (B) performed before 
the contrast media administration showed diffuse enphysema in upper lobes and the presence in the left upper lobe of a solid nodule (18 mm) with spiculated margins 
and bronchus sign, confirmed at small FOV reconstruction (C). Histological evaluation, after surgical intervention, demonstrated a breast cancer lung metastasis. 
HRCT: High resolution computed tomography.
A B
C
A B
C
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with difficult vascular anatomies due to its favourable 
outcomes, customised approach and easy technical 
execution[23­25]. Despite these advantages some articles 
debate the risk of long­term lifelong EVAR CT follow­
up, with a remarkable amount of radiation exposure 
carrying the risk of developing cancers; moreover 
they report the need of dose optimisations using new 
targeted CT protocols, considering that the absorbed 
dose by the patient differs on the basis different 
scanners, patient body size and age[26­28]. However 
to our knowledge there are no articles discussing the 
prevalence of lung cancer, prior to EVAR treatment, in 
patients with a smoking attitude. Furthermore, lung 
cancer represents the most important cause of death 
in the world, and the majority of patients suffering 
from lung cancer present mild or no symptoms, with 
nodular lesions being the most common presentation 
of peripheral lung adenocarcinoma[12]. Moreover, a 
large number of patients with vascular disease have a 
smoking history and, in particular, smoking is one of the 
major risk factors for developing vascular diseases. At 
the same time, smoking also represents the main risk 
factor for lung cancer due to the activation of the same 
inflammatory pathway with continuous endothelial 
damage. In our study we assess the prevalence of 
lung nodules through HRCT in a cohort of smoker 
patients who underwent abdominal CTA for planning 
or follow­up EVAR; considering the mean advanced 
age of patients (71 years), stochastic radiation damage 
deriving from the extra dose of HRCT (respectively 
mean CTDI 12.6 mGy (range 9.4­15.2) for HRCT vs 
22.3 mGy (19.8­24.3) for abdominal CTA) can be 
considered negligible, comparing to the benefit of early 
tumor detection; in fact 9 out of 102 nodules (8.8%) 
in 9 out of 181 (4.9%) patients were finally diagnosed 
as lung cancer with consequent surgery (6 patients), 
chemotherapeutic treatment (1 patient) or both (2 
patients), with a free survivor rate of 100% at one 
years. All the other patients were correctly addressed to 
the appropriate treatment or follow­up. In this context, 
performing HRCT of the lung to optimise morphological 
evaluation of lung nodules and/or adding advanced 
imaging procedure such as CT perfusion or CT volu­
metric assessment of lung nodules during CTA for the 
evaluation of vascular aneurysm, offers radiologists the 
possibility of performing a differential diagnosis between 
benign or malignant nodules, choosing the correct ma­
nagement for each patient[29­33]. Moreover, CTA can 
be performed in the emergency setting to exclude 
or confirm the presence of aneurysmal sac or EVAR 
complications or to investigate an abdominal pain after 
a doubtful ultrasound examination; incidental findings 
can also occur in that setting[34­37]. 
In fact several articles in the literature have reported 
the possibility of discovering coexistent neoplasms such 
as gastrointestinal and gall bladder cancers during CT 
examination of vascular patients[38­40]. 
Our study had some limitations. First of all, it is a 
retrospective study with some possible bias in patient 
selection, although the database used to find the 
patients was complete in medical records. Secondly, not 
all the patients underwent a prior chest radiography that 
could exclude patients with negative reports from the 
study. Additionally, a prospective study is mandatory 
to test the real impact of incidental findings in smoker 
patients who underwent EVAR planning or follow­up, in 
order to support the introduction of HRCT of the lung in 
the CT protocol for smoker patients. 
In conclusion, this study actually demonstrates the 
possibility of early diagnosis of lung cancers during CTA 
EVAR planning or follow­up, overcoming the concept of 
dose radiation induced neoplasms, especially in patients 
over the age of 65.
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smoker patients suffering from vascular disease, is underestimated.
Research frontiers
Nowadays the use of high resolution computed tomography (HRCT) in 
endovascular aortic aneurysm repair (EVAR) patients planning and follow up 
 COMMENTS
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Table 5  Incidental findings
Patients (n ) Findings
31 Pleural effusion
  5 Atelectasis 
  8 Pneumonia
16 Pericardial effusion
48 Cardiomegaly
57 Coronary artery calcifications
  0 Bone findings
23 Hiatal hernia
94 Emphysema 
39 Mediastinal or hilar adenopathy
Table 6  Computed tomography nodules characteristics
Nodules size n  (tot 102)
Pulmonary micronodule (< 4 mm) 43
Pulmonary nodule (> 4 mm and < 30 mm) 51
Pulmonary mass (> 30 mm)   8
Nodules characteristics n
Solid 73
Ground-glass 21
Partially solid   8
Spiculated   9
Smooth   4
Pleural tag   3
Bronchus sign   6 
Calcifications   7
Intralesion fat   4
Intralesional air   2
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is not recommended yet but this study demonstrates the possibility to early 
diagnose lung cancers during EVAR planning or follow-up, overcoming the 
concept of dose radiation induced neoplasms, especially in over 65 years old 
patients.
Innovations and breakthroughs
To be known, this is the first study using HRCT for the evaluation of vascular 
patients during EVAR planning or follow-up.
Applications
HRCT could play a key role in the diagnosis of incidental lung findings during 
the evaluation of vascular patients (EVAR planning or follow-up) and surely in 
the management. In particular HRCT can discriminate patients with urgent lung 
surgical evaluation for the presence of malignancy, from patients in which a 
follow-up can be proposed, increasing lifelong patients expectancy. 
Terminology
HRCT (high resolution computed tomography of the lung) before contrast agent 
administration, can lead a better evaluation of lung abnormalities enhancing 
nodule morphology and shape; CTA allows a better evaluation of vascular 
lumen during surgical planning and a correct assessment in cases of EVAR 
follow-up complications.
Peer-review
The manuscript is well written.
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